Ataxie cérébelleuse subaiguë : une atteinte atypique par le SARS-CoV-2 chez la personne âgée [Subacute cerebellar ataxia, an uncommon SARS-CoV-2 complication infection in older adults]
Détails
Télécharger: file.pdf (146.85 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_5D1A0AA3A243
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Ataxie cérébelleuse subaiguë : une atteinte atypique par le SARS-CoV-2 chez la personne âgée [Subacute cerebellar ataxia, an uncommon SARS-CoV-2 complication infection in older adults]
Périodique
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
02/11/2022
Peer-reviewed
Oui
Volume
18
Numéro
802
Pages
2053-2056
Langue
français
Notes
Publication types: Case Reports ; English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
Cerebellar ataxia can be caused by neoplasia, toxics (drugs, heavy metals, alcohol), infection, vascular lesions or auto-immune and paraneoplastic pathologies. Neuroimaging must be performed urgently in case of sudden onset and serologies as well as a lumbar puncture should be performed. Several case reports of ataxia associated with COVID-19 have been published, however the underlying pathogenic mechanisms remain unclear. This is a diagnosis of exclusion when other causes are ruled out and when the ataxia appears simultaneously to COVID-19 infection. We lack data on best management, but the prognosis appears mostly favorable with good functional recovery without any specific treatment. This paper describes the case of a patient who developed a cerebellar ataxia as the only neurological manifestation of a SARS-CoV-2 infection.
Mots-clé
Humans, Aged, Cerebellar Ataxia/etiology, Cerebellar Ataxia/complications, COVID-19/complications, SARS-CoV-2, Magnetic Resonance Imaging, Autoantibodies
Pubmed
Création de la notice
23/11/2022 9:31
Dernière modification de la notice
04/10/2023 6:11